Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Elevation of Serum Aminotransferase Levels and Future Risk of Death from External Causes: A Prospective Cohort Study in Korea.

Sohn J, Kang DR, Kim HC, Cho J, Choi YJ, Kim C, Suh I.

Yonsei Med J. 2015 Nov;56(6):1582-9. doi: 10.3349/ymj.2015.56.6.1582.

2.
3.

Personality disorders do not affect treatment outcomes for chronic HCV infection in Spanish prisoners: the Perseo study.

Marco A, Antón JJ, Trujols J, Saíz de la Hoya P, de Juan J, Faraco I, Caylà JA; Perseo Group..

BMC Infect Dis. 2015 Aug 19;15:355. doi: 10.1186/s12879-015-1102-x.

4.
5.

Pegylated interferon pharmacokinetics and self-reported depressive symptoms during antiviral treatment for chronic hepatitis C.

Evon DM, Esserman DE, Howell MA, Ruffin RA.

Pharmacopsychiatry. 2014 Sep;47(6):195-201. doi: 10.1055/s-0034-1385929.

7.

Anemia management in the era of triple combination therapy for chronic HCV.

Jacobson IM, Kowdley KV, Kwo PY.

Gastroenterol Hepatol (N Y). 2012 Sep;8(9 Suppl 6):1-16.

8.

Effect of pegylated interferon-α-2a treatment on mental health during recent hepatitis C virus infection.

Alavi M, Grebely J, Matthews GV, Petoumenos K, Yeung B, Day C, Lloyd AR, Van Beek I, Kaldor JM, Hellard M, Dore GJ, Haber PS; ATAHC Study Group..

J Gastroenterol Hepatol. 2012 May;27(5):957-65. doi: 10.1111/j.1440-1746.2011.07035.x.

9.

A biological pathway linking inflammation and depression: activation of indoleamine 2,3-dioxygenase.

Christmas DM, Potokar J, Davies SJ.

Neuropsychiatr Dis Treat. 2011;7:431-9. doi: 10.2147/NDT.S17573.

10.

Risk factors for the development of depression in patients with hepatitis C taking interferon-α.

Smith KJ, Norris S, O'Farrelly C, O'Mara SM.

Neuropsychiatr Dis Treat. 2011;7:275-92. doi: 10.2147/NDT.S13917.

11.

Peginterferon with or without ribavirin has minimal effect on quality of life, behavioral/emotional, and cognitive outcomes in children.

Rodrigue JR, Balistreri W, Haber B, Jonas MM, Mohan P, Molleston JP, Murray KF, Narkewicz MR, Rosenthal P, Smith LJ, Lobritto SJ, Schwarz KB, Robuck PR, Barton B, González-Peralta RP.

Hepatology. 2011 May;53(5):1468-75. doi: 10.1002/hep.24248.

12.

Prophylactic antidepressant treatment in patients with hepatitis C on antiviral therapy: a double-blind, placebo-controlled trial.

Morasco BJ, Loftis JM, Indest DW, Ruimy S, Davison JW, Felker B, Hauser P.

Psychosomatics. 2010 Sep-Oct;51(5):401-8. doi: 10.1176/appi.psy.51.5.401.

13.

Review article: adherence to medication for chronic hepatitis C - building on the model of human immunodeficiency virus antiretroviral adherence research.

Weiss JJ, Bräu N, Stivala A, Swan T, Fishbein D.

Aliment Pharmacol Ther. 2009 Jul;30(1):14-27. doi: 10.1111/j.1365-2036.2009.04004.x. Review.

Supplemental Content

Support Center